academic article

• A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results..  Journal of the American Academy of Dermatology.  85:379-387. 2021
• Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. 2013
• Clinical and Translational Scientist Career Success: Metrics for Evaluation..  Clinical and translational science.  5:400-407. 2012